Related by context. Frequent words. (Click for all words.) 63 IND submission 63 Phase III Clinical Trial 61 FDA Accepts 60 Complete Response 60 Pivotal Phase III 59 PMA submission 59 Patient Enrollment 58 Plenaxis R 58 Complete Response letter 58 Clinical Trial Results 58 ISTODAX 58 liprotamase 58 Approvable Letter 58 Phase III Trial 57 approvability 57 AVAX 57 Scientific Advice 57 Pivotal Phase 57 BioDelivery Sciences 57 Icatibant 57 Pivotal Trial 57 Marketing Authorization Application 57 Act PDUFA date 57 orphan designation 56 Drug Candidate 56 Fast Track Designation 56 Telavancin 56 Investigational Device Exemption 56 AeroLEF 56 KRN# 56 Panzem R 56 QbD 55 Cethromycin 55 Pirfenidone 55 Phenoptin 55 Pulmonary Arterial Hypertension 55 Orphan Drug Status 55 alvimopan 55 FDA approvable letter 55 Marketing Authorization 55 Bicifadine 55 ATL# [001] 55 Aliskiren 55 Arpida 55 Oncologic Drugs Advisory 55 FDA Advisory Panel 55 Amigal 55 NEBIDO 55 anticancer compound 54 Guanilib 54 Clinical Trial Application 54 preclinical toxicology 54 Monotherapy 54 Positive Opinion 54 IMVAMUNE R 54 Phase IIB 54 Urocidin 54 tanespimycin 54 Completes Enrollment 54 prGCD 54 QNEXA 54 TOLAMBA 54 supplemental Biologics License Application 54 BLA submission 54 Menerba 54 QRxPharma 54 Octreotide 54 IIa trial 54 Citizen Petition 54 MHLW 53 registrational trial 53 Biosimilar 53 SABCS 53 SILENOR TM 53 Combidex 53 PhosLo 53 Orphan Drug status 53 ganetespib 53 CDER 53 Mitigation Strategy REMS 53 Complete Response Letter 53 eniluracil 53 Generic Version 53 Clinical Trial 53 romidepsin 53 Restanza 53 Avanafil 53 confirmatory Phase III 53 Mipomersen 53 Vilazodone 53 alogliptin 53 Phase IIa clinical trials 53 Patent Covering 52 elotuzumab 52 pafuramidine 52 TOCOSOL Paclitaxel 52 MONOVISC 52 Diabetic Macular Edema 52 PDUFA date 52 Market Approval PMA 52 anti CD# monoclonal